CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205894398
- Phone
- (888) 958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- DEFC14A Other DEFC14A
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- PRRN14A Other PRRN14A
- 4 Open-market buy CCO & EVP, Bus. Development bought 2,000 shares at $4.61 ($9,218)
- DEFA14A Proxy Proxy Materials
- DEFC14A Other DEFC14A
- PRER14A Other PRER14A
- 4 Open-market buy Director bought 11,000 shares at $4.20 ($46,148)
- 4 Open-market buy SVP, Corporate Controller bought 1,200 shares at an average $4.14 ($4,967)
- 4 Open-market buy CFO, Secretary & Treasurer bought 1,725 shares at $4.15 ($7,159)
- 4 Open-market buy Director bought 5,000 shares at $4.15 ($20,732)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $4.20 ($41,978)
- 8-K Event Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- DEFA14A Proxy Proxy Materials
- 8-K Event Results of operations
Page 14 of 44 · 870 filings